Facebook
X
LinkedIn
ForwardSymposium Guide
2025 Baptist Health Biomedical Research Symposium
Friday, September 12, 2025
Test
Quick Links
Claim CME/CE Credit
Option 1: Text the six-letter code provided at the end of the symposium to (754) 203-8885. You will receive a message confirming your attendance.
Option 2: Scan the QR code shown below with your mobile phone, and enter the six-letter code provided at the symposium to receive your credit.
Evaluation
Once you have claimed your CME/CE credit, you will receive a link to your evaluation form via email and SMS.
Presentations
| 7:30 a.m. | Breakfast and Registration |
| 8:00 a.m. | Introductions Scott Lipkin, DPM / Jack Ziffer, Ph.D., M.D. / Juan C. Cendan, M.D. |
| 8:15 a.m. | Panel 1 Moderator: Manmeet Ahluwalia, M.D. |
| 8:20 a.m. | Multi-center Phase 2 Trial of Stereotactic Magnetic Resonance Image Guided Adaptive Radiation Therapy in One Fraction (SMART ONE) Michael Chuong, M.D. |
| 8:30 a.m. | Radiation Therapy Alone Versus Radiation Therapy Plus Radiofrequency Ablation/Vertebral Augmentation For Painful Spine Metastasis: A Phase 2 Randomized Controlled Trial Rupesh Kotecha, M.D. |
| 8:40 a.m. | Systemic Rintatolimod and IFNa2b in Patients with Unresectable Chemotherapy-Resistant Liver-Metastatic Colorectal Cancer Sarbajit Mukherjee, M.D. |
| 8:50 a.m. | Pemetrexed and Zanubrutinib Combination in R/R CNS B-cell Lymphoma: Preliminary Report of the Safety Lead-in Cohort in a Single Center Phase II Study Yuliya Linhares, M.D. |
| 9:00 a.m. | Panel Discussion |
| 9:20 a.m. | Panel 2 Moderator: Stephen Black, Ph.D. |
| 9:25 a.m. | Analysis of the CAR-T Cell Glycome to Evade Galectin-mediated Immunosuppression: A Research Update Charles J. Dimitroff, Ph.D. / Manmeet Ahluwalia, M.D. |
| 9:35 a.m. | Development of Proteasome Inhibitors for the Treatment of Glioblastoma Kyung Bo Kim, Ph.D. / Manmeet Ahluwalia, M.D. |
| 9:45 a.m. | Development of Novel Therapeutics for Glioblastoma Targeting RNA Methylation Ting Wang, Ph.D. and Adel Nefzi, Ph.D. |
| 9:55 a.m. | Uncovering the Mechanisms of Pain Relief by Peripheral Transcutaneous Magnetic Stimulation (pTMS) Saurabh Aggarwal M.D., Ph.D. |
| 10:05 a.m. | Questions & Answers |
| 10:15 a.m. | Panel Discussion |
| 10:40 a.m. | Panel 3 Moderator: Hoshang Jehangir Unwalla, Ph.D. |
| 10:45 a.m. | Progress Toward the Development of Glycoprotein Biomarkers for Early Detection of Oral Cancer Kevin Brown Chandler, Ph.D. |
| 11:00 a.m. | Extracting More Information From Meningioma Samples Jose Otero, M.D. / Maria M. Abreu, Ph.D. |
| 11:10 a.m. | Circulating Extracellular Vesicles as Biomarkers for Early Detection of Malignant Neoplasms of the Lung David Marciano, M.D. / Maria M. Abreu, Ph.D. |
| 11:20 a.m. | Exploring Subjective Cognitive Decline and Resting-State Default Mode Network as an Early Biomarker for Dementia Detection Patricia Junquera, M.D. / G. Peter Gliebus, M.D. |
| 11:30 a.m. | Panel Discussion |
| 11:40 a.m. | Panel 4 Moderator: Scott Lipkin, DPM |
| 11:45 a.m. | HEMERA 1 Clinical Trial: Phase 1 Results and Propensity Score Analysis Italio Linfante, M.D. |
| 11:55 a.m. | Advancing Treatment of Complex Aortic Diseases W. Anthony Lee, M.D. |
| 12:05 a.m. | Drug Coated Balloon Technology in Peripheral Vascular Disease Constantino Peña, M.D. |
| 12:15 a.m. | Early Experience of Robotic Single Port Platform in General Surgery Anthony Gonzalez, M.D. |
| 12:25 a.m. | Predicting Cognitive Improvement in Patients with Normal Pressure Hydrocephalus G. Peter Gliebus, M.D. |
| 12:35 p.m. | Panel Discussion |
| 12:50 p.m. | Closing Remarks Scott Lipkin, DPM |
| 1:00 p.m. | Networking Lunch for Attendees |
| 2:00 p.m. | Adjourn |
NOTE: Schedule subject to change.
Join the conversation #MiamiBrain23
Follow @BaptistHealthSF and @BaptistCME on X/Twitter
Follow Baptist Health and Baptist Health CME on LinkedIn